ReShape Lifesciences OTC Markets

RSLS

US7611236032

Advanced Medical Equipment & Technology

End-of-day quote OTC Markets Other stock markets 23:00:00 07/07/2021 BST			5-day change	1st Jan Change
5.09 ^USD	+23.84%		-.--%	-.--%

07-09	ReShape Signs Merger Agreement With Vyome, Asset Sale Deal With Biorad; Shares Rise	MT
07-09	Ninjour Health International Limited agreed to acquire Assets of ReShape Lifesciences Inc for $5.2 million.	CI

ReShape Lifesciences Inc.(OTCPK:RSLS) dropped from S&P TMI Index

January 02, 2019 at 05:00 am

Latest news about ReShape Lifesciences

ReShape Signs Merger Agreement With Vyome, Asset Sale Deal With Biorad; Shares Rise	07-09	MT
Ninjour Health International Limited agreed to acquire Assets of ReShape Lifesciences Inc for $5.2 million.	07-08	CI
ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024	05-15
Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M	05-15	MT
North American Morning Briefing : Big Banks Kick -2-	04-12	DJ
Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024	04-01
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	03-29	CI
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	03-29	CI
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	03-29	CI
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	03-29	CI
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System	03-28	MT
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System	03-28	CI
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex	02-22	CI
Top Midday Gainers	12-13	MT
North American Morning Briefing : Traders Await FOMC, Powell	12-13	DJ
ReShape Lifesciences®? Receives FDA PMA Supplement Approval for Its Next-Generation Lap-Band®? 2.0 FLEX	12-12	CI
ReShape Lifesciences Gets FDA Approval for PMA Supplement Used in Latest Lap-Band	12-12	DJ
ReShape Lifesciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
ReShape Lifesciences Inc. Reports Impairment of Long-Lived Assets for the Third Quarter Ended September 30, 2023	11-09	CI
Transcript : ReShape Lifesciences Inc., Q3 2023 Earnings Call, Nov 08, 2023	11-08
Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q3 Revenue $2.2M, vs. Street Est of $2.4M	11-08	MT
Sector Update: Health Care Stocks Lower Late Afternoon	29/09/23	MT
Sector Update: Health Care Stocks Declining Friday Afternoon	29/09/23	MT

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Sector

Advanced Medical Equipment & Technology

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+2.62%	209B
DANAHER CORPORATION	+6.44%	183B
INTUITIVE SURGICAL, INC.	+29.61%	158B
BOSTON SCIENTIFIC CORPORATION	+34.96%	114B
SIEMENS HEALTHINEERS AG	+3.84%	67.29B
EDWARDS LIFESCIENCES CORPORATION	+17.38%	54.83B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.88B
AGILENT TECHNOLOGIES, INC.	-5.77%	38.58B
GE HEALTHCARE TECHNOLOGIES INC.	+3.71%	36.65B

Other Advanced Medical Equipment & Technology

ReShape Lifesciences OTC Markets

Equities

RSLS

US7611236032

Advanced Medical Equipment & Technology

ReShape Lifesciences Inc.(OTCPK:RSLS) dropped from S&P TMI Index

Latest news about ReShape Lifesciences

Chart ReShape Lifesciences

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology